Growing community of inventors

Copenhagen, Denmark

Ian Sarvary

Average Co-Inventor Count = 6.77

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 9

Ian SarvaryAlex Haahr Gouliaev (8 patents)Ian SarvarySanne Schrøder Glad (8 patents)Ian SarvaryLuigi Piero Stasi (8 patents)Ian SarvaryThomas Franch (4 patents)Ian SarvaryLene Teuber (3 patents)Ian SarvarySøren Jensby Nielsen (3 patents)Ian SarvaryMontserrat Erra Solà (3 patents)Ian SarvaryNiels Grøn Nørager (3 patents)Ian SarvaryJoan Taltavull Moll (3 patents)Ian SarvaryJuan Francisco Caturla Javaloyes (2 patents)Ian SarvaryLluís Miquel Pagès Santacana (2 patents)Ian SarvaryLorena Taboada Martínez (2 patents)Ian SarvaryKim Birkebæk Jensen (1 patent)Ian SarvaryMikkel Vestergaard (1 patent)Ian SarvaryPaul Robert Eastwood (1 patent)Ian SarvaryIan Sarvary (8 patents)Alex Haahr GouliaevAlex Haahr Gouliaev (36 patents)Sanne Schrøder GladSanne Schrøder Glad (14 patents)Luigi Piero StasiLuigi Piero Stasi (8 patents)Thomas FranchThomas Franch (25 patents)Lene TeuberLene Teuber (44 patents)Søren Jensby NielsenSøren Jensby Nielsen (3 patents)Montserrat Erra SolàMontserrat Erra Solà (3 patents)Niels Grøn NøragerNiels Grøn Nørager (3 patents)Joan Taltavull MollJoan Taltavull Moll (3 patents)Juan Francisco Caturla JavaloyesJuan Francisco Caturla Javaloyes (2 patents)Lluís Miquel Pagès SantacanaLluís Miquel Pagès Santacana (2 patents)Lorena Taboada MartínezLorena Taboada Martínez (2 patents)Kim Birkebæk JensenKim Birkebæk Jensen (4 patents)Mikkel VestergaardMikkel Vestergaard (2 patents)Paul Robert EastwoodPaul Robert Eastwood (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Nuevolution A/s (8 from 31 patents)


8 patents:

1. 12441704 - Compounds active towards nuclear receptors

2. 11780843 - Compounds active towards nuclear receptors

3. 11685727 - Compounds active towards nuclear receptors

4. 11613532 - Compounds active towards nuclear receptors

5. 11447479 - Compounds active towards nuclear receptors

6. 11254681 - Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

7. 10689383 - Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

8. 10683293 - Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…